Desmopressin does not decrease blood loss and transfusion requirements in patients undergoing hepatectomy
- PMID: 12514144
- DOI: 10.1007/BF03020180
Desmopressin does not decrease blood loss and transfusion requirements in patients undergoing hepatectomy
Abstract
Purpose: To determine the effects of desmopressin on coagulation and blood loss in patients undergoing elective partial hepatectomy.
Methods: A randomized, controlled and double-blind study on 59 patients who received either 0.3 micro g x kg(-1) of desmopressin or an equal volume of normal saline (control) infused intravenously over 20 min after induction of general anesthesia.
Results: There was an increase in plasma levels of factors VIII and von Willebrand after the infusion of study drug in both groups (P < 0.001). The activated partial thromboplastin time was shortened in Group D whereas prothrombin time was prolonged in Group C; (P = 0.02). A large range of intraoperative blood loss (400-7128 mL) was observed, with no significant differences between groups. There were no changes in plasma electrolyte levels or osmolality. Transfusion requirements were similar in both groups.
Conclusion: Desmopressin did not reduce intraoperative blood loss or transfusion requirements during hepatectomy despite raising clotting factor levels and improving tests of hemostasis.
Comment in
-
Desmopressin before liver transplantation.Can J Anaesth. 2003 Aug-Sep;50(7):748-9. doi: 10.1007/BF03018721. Can J Anaesth. 2003. PMID: 12944453 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical